Cargando…
Chemoradiation induces upregulation of immunogenic cell death-related molecules together with increased expression of PD-L1 and galectin-9 in gastric cancer
Surgery alone or combined with chemo- and/or radiation therapy remains the primary treatment for gastric cancer (GC) to date and immunotherapeutic tools such as monoclonal antibodies are only slowly being implemented. This is partly due to the fact that the immune microenvironment in GC during chemo...
Autores principales: | Petersen, S. H., Kua, L. F., Nakajima, S., Yong, W. P., Kono, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192931/ https://www.ncbi.nlm.nih.gov/pubmed/34112882 http://dx.doi.org/10.1038/s41598-021-91603-7 |
Ejemplares similares
-
Upregulation of Galectin-9 and PD-L1 Immune Checkpoints Molecules in Patients with Chronic Lymphocytic Leukemia
por: Taghiloo, Saeid, et al.
Publicado: (2017) -
Immune checkpoint molecules soluble program death ligand 1 and galectin‐9 are increased in pregnancy
por: Enninga, Elizabeth Ann L., et al.
Publicado: (2017) -
Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
por: Yang, Riyao, et al.
Publicado: (2021) -
Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death
por: Yang, Riyao, et al.
Publicado: (2022) -
Galectin-1 Promotes Vasculogenic Mimicry in Gastric Cancer by Upregulating EMT Signaling
por: You, Xiaolan, et al.
Publicado: (2019)